Loxo Oncology Inc buy stratec
Start price
17.05.18
/
50%
€144.77
Target price
09.01.19
€171.38
Performance (%)
44.82%
End price
09.01.19
€209.65
Summary
This prediction ended on 09.01.19 with a price of €209.65. The BUY prediction by stratec for Loxo Oncology Inc saw massive gains of 44.82%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Loxo Oncology Inc | - | - | - | - |
| iShares Core DAX® | -1.042% | 2.220% | 14.279% | 15.463% |
| iShares Nasdaq 100 | -1.361% | 3.207% | 26.657% | 53.266% |
| iShares Nikkei 225® | -0.044% | -1.680% | 5.941% | 4.271% |
| iShares S&P 500 | -0.480% | 2.165% | 23.067% | 45.283% |
Comments by stratec for this prediction
In the thread Loxo Oncology Inc diskutieren
Bayer und Loxo bei Larotrectinib auf Kurs, mit einer Übernahme, die Sinn macht!
https://seekingalpha.com/news/3357468-loxo-oncology-plus-18-percent-cancer-drug-shows-promise-early-trial
https://www.deutsche-apotheker-zeitung.de/news/artikel/2018/03/26/bayer-und-loxo-bei-larotrectinib-auf-kurs
(Vom Mitglied beendet)